Clinical trial
To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop…
NCT00493064 · Palo Alto Medical Foundation, Other · Completed
Key facts
| NCT number | NCT00493064 |
|---|---|
| Title | To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions |
| Official title | Niacin (as a Vasodilator), and a Topical Steroid (for Macular Edema), Non-Ischemic CRVO,HRVO,BRVO |
| Lead sponsor | Palo Alto Medical Foundation, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Retinal Vein Occlusion |
| Intervention type | Drug |
| Interventions | Nicotinic acid, Prednisolone acetate |
| Enrollment | 63 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2016 |
| Completion | Oct 1, 2016 |
| First posted | Jun 27, 2007 |
| Last update posted | Dec 21, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: